Showing results (451-460 of 524) with videos related to

Sort By:
Pageof 53
Frontiers in Immunology|February 24, 2023
Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaquesMary S Pampusch, Emily N Sevcik, Zoe E Quinn, et al.
Head & Neck Oncology|April 21, 2012
A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancerKyle Wang, Dwight E Heron, John C Flickinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in AustraliaAnthony T Newall, Julia M L Brotherton, Helen E Quinn, et al.
Cognitive, Affective & Behavioral Neuroscience|April 3, 2019
Emotional content impacts how executive function ability relates to willingness to wait and to work for rewardKatherine S F Damme, Nicholas J Kelley, Meghan E Quinn, et al.
Lab Animal|October 21, 2011
Prevalence of viral, bacterial and parasitological diseases in rats and mice used in research environments in Australasia over a 5-y periodElizabeth F McInnes, Lorna Rasmussen, Peony Fung, et al.
The Journal of Pathology|December 23, 2011
BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesotheliomaSara Busacca, Michael Sheaff, Kenneth Arthur, et al.
Neurosurgery|September 26, 2017
Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and CounselingEmile Gogineni, John A Vargo, Scott M Glaser, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2018
Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late ToxicityDiane C Ling, John C Flickinger, Steven A Burton, et al.
Physical Therapy|February 12, 2020
The Correlative Strength of Objective Physical Assessment Against the ECOG Performance Status Assessment in Individuals Diagnosed With CancerSarah E Quinn, Catherine E Crandell, Morgan E Blake, et al.
Radiation Oncology (London, England)|November 2, 2013
Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancerMalolan S Rajagopalan, Dwight E Heron, Rodney E Wegner, et al.
Pageof 53